Practice Areas
- FDA & Healthcare
- Pharmaceuticals & Biologics
- Medical Devices & Radiological Products
- Medicare and Medicaid Reimbursement and Payment
- Life Sciences
- False Claims Act and Qui Tam Litigation
- Privacy
- Hospitals, Health Systems, and Academic Medical Centers
- Healthcare Specialty Providers & Suppliers
- Healthcare
Bar Admissions
- District of Columbia
- New York
- Washington, D.C.
-
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5960
Fax: 202.739.3001
63 Publications Found
| Date | Title | Publication |
| 03/19/13 |
Differential Charging to medicare and Self-Pay and Commercial Payors, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 02/28/13 |
Analyzing the Current and Possible Future Part B Reimbursement Landscape |
Speech |
| 01/28/13 |
Incentivizing Quality Improvement – Better to Appeal to ProfessionalPride or Pocketbook? |
Speech |
| 01/16/13 |
Minimizing FCA Liability Attaching to Price Reporting when Making Reasonable Assumptions, presented at the American Conference Institute’s 10th NationalRx Drug Pricing Boot Camp |
Speech |
| 09/12/12 |
Recent Part D Changes – Implications for Pharmaceutical Manufacturers, presented for FX Conferences |
Speech |
| 07/20/12 |
Massachusetts Amends Anti-Kickback Law |
Life Sciences and Healthcare LawFlash |
| June 2012 |
Manufacturers Affected by Recent Medicare Part D Rule, LMG Life Sciences 2012 |
Article |
| 2012 |
Out of Bounds: CMS Proposed Rule
for AMP Under Medicaid, PLC's Multi-Jurisdictional Guide 2012: Life Sciences |
Article |
| 05/22/12 |
Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges, presented at the AHLA/FDLI's Intersecting Worlds of Drug, Device, Biologics and Health Law |
Speech |
| 04/18/12 |
Manufacturers Affected by Recent Medicare Part D Rule |
Life Sciences and Healthcare LawFlash |
| 03/29/12 |
HACs, Readmissions and VBP: Hospital Strategies for Turning Lemons into Lemonade, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore, MD |
Speech |
| 02/06/12 |
CMS Proposes Major Changes to AMP Rule |
Life Sciences and Healthcare LawFlash |
| 11/16/11 |
Avoiding Anti-Kickback Challenges Related to Pricing and Contracting, presented at the 8th National Rx Drug Pricing Boot Camp, New York |
Speech |
| 03/01/11 |
Medicare Part D and the Coverage Gap Discount Program, presented at ACI’s 9th Annual Advanced Forum on Government Regulation of Prescription Drug Pricing, New York |
Speech |
| 11/18/10 |
Understanding the Interrealtionship of Pricing Methodologies and How One Price May Affect Another, presented at ACI's Prescription Drug Pricing Boot Camp |
Speech |
| 11/15/10 |
USP to Update Medicare Model Guidelines |
FDA and Healthcare LawFlash |
| 07/06/10 |
Price Reporting and Governmental Rebate Issues Arising from the Healthcare Reform Law—an Early Assessment |
Washington Government Relations and Public Policy LawFlash |
| 04/13/10 |
Healthcare Reform Law: Issues Affecting Hospitals and Health Systems |
Washington Government Relations and Public Policy LawFlash |
| 01/23/09 |
CMS Regulation Addresses Protected Drug Categories and Classes |
FDA and Healthcare LawFlash |
| 06/29/08 |
Off-Label Use of Drugs and Devices, presented at the American Health Lawyers Association's 2008 In-House Counsel Program & Annual Meeting, San Francisco |
Speech |
| 11/15/07 |
Implications of CMS Clinical Research Policy, presented as a webinar for The Center for Business Intelligence |
Speech |
| 07/18/07 |
CMS Proposes Changes to Its Policies Governing Off-Label Uses of Anticancer Drugs and Biologicals |
FDA and Healthcare LawFlash |
| 03/22/07 |
The Patient's Nose Under the Tent: The Impact on Hospitals of State and Federal Healthcare Transparency Initiatives, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 03/21/07 |
2006: The RAP Practice Group's Year in Review, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 03/02/07 |
Potential Challenges to Pricing of Biotech Products: Medicare/Medicaid and Related Pricing Developments, presented at the 2007 BIO General Counsels' Committee Meeting |
Speech |
